针对高级非小细胞肺癌的免疫疗法最新情况:优化治疗顺序并确定最佳选择
Katia Roque1,2,3,4, Rossana Ruiz2,5, Luis Mas2,3,6
1Discipline of Medical Oncology, Post-Graduation Programme in Medicine, Faculty of Medicine, Nine of July University (UNINOVE), São Paulo 04101-000, Brazil.
Cancers
|September 28, 2023
概括
免疫疗法,包括免疫检查点抑制剂 (ICI),已经彻底改变了高级非小细胞肺癌 (NSCLC) 治疗. 这一审查详细介绍了ICI的细节.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 先进的非小细胞肺癌 (NSCLC) 管理已经被免疫疗法所改变.
- 免疫检查点抑制剂 (ICI) 现在是治疗的基石,特别是对于缺乏瘤驱动突变的患者.
- 抗细胞毒性T淋巴细胞抗原-4 (anti-CTLA-4) 和抗编程细胞死亡-1/联结体 (anti-PD-1/PD-L1) 药物包括ICI.
研究的目的:
- 提供关于高级NSCLC免疫疗法的最新进展的全面概述.
- 突出ICI的作用机制,疗效和安全概况.
- 讨论NSCLC免疫疗法的临床意义和未来方向.
主要方法:
- 关键临床试验和长期疗效和安全数据的综述.
- 对当前一线免疫治疗方法的分析:单疗法,免疫治疗专用方案和化疗组合.
- 探索新兴生物标志物和新的治疗策略.
主要成果:
- 免疫疗法显著改善了晚期NSCLC的预后.
- 治疗场景包括各种基于ICI的策略,由于有限的直接比较数据而导致决策的复杂性.
- 目前正在进行的研究重点是通过生物标志物和创新疗法来改进治疗.
结论:
- ICI代表了先进的NSCLC治疗的重大突破,为患者提供了更好的治疗结果.
- 优化治疗选择需要仔细分析临床试验中的疗效和安全性数据.
- 未来的研究旨在进一步个性化和增强NSCLC免疫疗法.
关键词:
在 CTLA-4 中.在PD-1中使用PD-1.在PD-L1中.免疫检查点抑制剂 (ICI)非小细胞肺癌 (NSCLC) 是一种非小细胞肺癌.致癌驱动基因突变的发生.个性化医疗是个性化的医疗.治疗顺序的顺序处理.这些是瘤生物标志物.更多相关视频
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.0K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
相关概念视频
01:27Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:30Cancer Vaccines
396
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
396
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K